Open Email...Your Options Trades Ideas (Around Earnings Announcements) Inside
 | Unsubscribe |
|
| |
| Dear Fellow Trader, | | I hope this trading day has been good to you! I am sending you trade ideas for tomorrow. So you can have enough time to take action on our trades ideas. | This Revolutionary Biotech Just Hit the NASDAQ (ad)*
The drugs we've been taking for years are due for a major upgrade and THIS company is making it happen. It is aiming for FDA approval of its sublingual aspirin products, and after a recent Wall Street debut, now may be the ideal time to have the company on your watch list!
Click here for the name and ticker symbol | | Options Trade Ideas (Volatility Rush Strategy) | | The basic option trade idea is to buy an at-the-money straddle while the options premium is cheap. | | In assessing this trade, you need to do your homework to ensure you are not paying too much for the straddle. | | As the earnings date approaches, the implied volatility (IV) should increase, resulting in greater price movement. | | However, be aware that you should close your position before the announcement comes out in order to maximize your profit potential. That's because once earnings are released, IV will fall dramatically, which will greatly reduce your opportunity to profit on the trade. | | The stocks (with Weekly Options) below are announcing earnings in next few weeks. Our proprietary volatility algorithm suggests these stocks are likely to experience high volatility as earnings day approaches. | | | |  | Before Market Open |  | After Market Close | | | *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. | This Nasdaq-Listed Biopharma Company is shaping the future of medicine. (ad)*
With an innovative drug delivery mechanism that aims to help save millions of lives with its first to market product. The Company has assembled a world class team and is led by a CEO who has achieved more than $1B market caps on not one, but two previous companies!
Click here for the full story. | Investors Pay Attention: FDA Fast-Track Potential – Aspire's aspirin formulation is eligible for the FDA's 505(b)(2) pathway (ad)*
With its innovative tech and a massive global market, this Nasdaq-listed biopharma Company is ready to lead the future of medicine.
Click Here to Learn More >>> | | At StockEarnings, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. | | To your trading success, | | Hiral Ghelani | | Founder & CEO | | StockEarnings, Inc | | 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | | W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) | | |
| | (ad)* This message is a PAID ADVERTISEMENT for Aspire Bio Labs (NASDAQ: ASBP) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $10,000 for multiple Dedicated Email Sends, Newsletter Sponsorship, and SMS sends between April 11, 2025 and April 17, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Aspire Bio Labs (NASDAQ: ASBP) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Aspire Bio Labs (NASDAQ: ASBP) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and Aspire Bio Labs (NASDAQ: ASBP). StockEarnings, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. | Unsubscribe
Today's Bonus Content: Unlock Hidden Gems with Our Free Wealth Building Report!
(By clicking this link, you are subscribing to receive emails from Krypton Street Newsletter) | |
ليست هناك تعليقات:
إرسال تعليق